Sfoglia per Rivista
In vivo activation of the human δ-globin gene: the therapeutic potential in β- thalassemic mice
2014-01-01 Manchinu M., F; Marongiu M., F; Poddie, D; Casu, C; Latini, Veronica; Simbula, M; Galanello, R; Moi, Paolo; Cao, A; Porcu, S; Ristaldi, M. S.
Incidence of non-Hodgkin's lymphoma and Hodgkin's disease in Sardinia, Italy: 1974-1993
2001-01-01 Broccia, G; Cocco, PIER LUIGI; Casula, P.
Incidenza del difetto della G-6-PD eritrocitaria, della ß e α-Talassemia nella Sardegna Meridionale: risultati di tre anni di screening
1985-01-01 Frigerio, R; Cacace, Enrico; Sole, G; Olla, N; Lovicu, M; Passiu, G; Perpignano, G; Pitzus, F; Carcassi, U.
Interferon-alpha 2a therapy in CML: disappearance of BCR/ABL transcript in a case of long-lasting continuous cytogenetic conversion
1994-01-01 Pardini, S; Addis, Maria; Dore, F; Bonfigli, S; Nieddu, Rm; Galanello, R; Longinotti, M; Pau, Mg
INTERIM RESULTS FROM A PHASE 2A, OPEN-LABEL, DOSE FINDING STUDY OF SOTATERCEPT (ACE-011) IN ADULT PATIENTS (PTS) WITH BETA-THALASSEMIA
2015-01-01 Cappellini, Md; Porter, J; Origa, Raffaella; Forni, Gl; Voskaridou, E; Taher, At; Laadem, A; Galacteros, F; Miteva, D; Sung, V; Chopra, R; Arlet, Jb; Ribeil, Ja; Zou, J; Chen, N; Attie, Km; Garbowski, M; Graziadei, G; Balocco, M; Hermine, O.
INTERIM RESULTS FROM A PHASE 2A, OPEN-LABEL, DOSE-FINDING STUDY TO DETERMINE THE SAFETY, EFFICACY, AND TOLERABILITY OF SOTATERCEPT (ACE-011) IN ADULTS WITH BETA-THALASSEMIA
2014-01-01 Porter, J; Cappellini, Md; Origa, Raffaella; Forni, Gl; Laadem, A; Galacteros, F; Voskaridou, E; Miteva, D; Sung, V; Chopra, R; Arlet, Jb; Ribeil, Ja; Klesczewski, K; Attie, K; Garbowski, M; Graziadei, G; Balocco, M; Hermine, O.
Internal tandem duplication, d835 mutation in acute myeloid and promielocitic leukemia
2005-01-01 Culurgioni, F; Ennas, MARIA GRAZIA; Adamo, Mf; Pala, G; Tavera, Ml; Zucca, Mariagrazia; Lilliu, S; Angelucci, E.
INVESTIGATING PRETREATMENT QUALITY OF LIFE AND SYMPTOMATOLOGY IN NEWLY DIAGNOSED HIGH-RISK PATIENTS WITH MYELODYSPLASIA. GIMEMA AND EORTC QUALITY OF LIFE GROUP
2010-01-01 Efficace, F; Angelucci, E; Sprangers, M; Gaidano, G; Caocci, Giovanni; Breccia, M; Voso, Mt; Staudere, R; Selleslag, D; Lubbert, M; Cascavilla, N; Rauzy, B; Chonghua, W; Specchia, G; Chie, W; Focan, C; Cottone, F; Vignetti, M; Mandelli, F.
Iron chelation therapy with deferasirox in transfusion dependent myelodysplastic syndrome patients. first report From the prospective MDS0306 gimema trial
2010-01-01 Angelucci, E; Di Tucci, A; Santini, V; Poliani, E; Finelli, C; Della Casa, C; Cantore, N; Caocci, Giovanni; D’Arco, Am; Vallisa, D; Foà, R; Quarta, G; Morra, E; Annino, L; Saglio, G; Cascavilla, N; Levis, A; Porcedda, S; Picciocchi, A; Vignetti, M; Tura, S.
Iron chelation therapy with deferasirox in transfusion dependent myelodysplastic syndrome patients. Report from the prospective MDS0306 GIMEMA trial
2011-01-01 Angelucci, E; Santini, V; Caocci, Giovanni; Rambaldia, A; Finelli, C; Pogliani, Em; Quarta, G; Di Tucci, A; Levis, A; Cantore, N; D'Arco, Am; Saglio, G; Cascavilla, N; Morra, E; Vallisa, D; Alimena, G; Voro, Mt; Annino, L; Pilo, F; Piciocchi, A; Vignetti, M; Tura, S.
Is the experience mutation of G-CSF truly a predictive indicator of trends in early myolodysplasia or leukemia?
2008-01-01 Tucci, F; Giunti, L; Gambineri, Eleonora; Tondo, A; Giglio, SABRINA RITA; Sainati, L; Arico, M.
Kir haplotype aa is a possible predictive marker of complete molecular response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia
2013-01-01 Caocci, Giovanni; LA NASA, Giorgio; Littera, R; Atzeni, S; Vacca, A; Mulas, O; Langiu, M; Greco, M; Orru, Sandro; Orrù, N; Usai, M; Floris, A; Carcassi, Carlo
La ferritina sierica nei Beta -talassemici dopo trapianto di midollo osseo: dati preliminari su due diversi tipi di comportamento
1987-01-01 LA NASA, Giorgio; Arras, M; Vacca, A; Pizzati, A; Zuccarelli, A; Atzeni, S; Mela, Quirico; ZORCOLO G., P; Mulargia, M; Carcassi, Carlo; Lucarelli, G; Contu, L.
Livelli della HbA1c in soggetti G-6-PD carenti
1985-01-01 Frigerio, R; Passiu, G; Sole, G; Olla, N; Lovicu, M; Mela, Quirico; Perpignano, G; Pitzus, F; Carcassi, U.
Liver iron concentrations and urinary hepcidin in beta-thalassemia
2007-01-01 Origa, Raffaella; Galanello, R; Ganz, T; Giagu, N; Maccioni, L; Faa, Gavino; Nemeth, E.
Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: Key role of interleukin-6
2018-01-01 Madeddu, Clelia; Gramignano, Giulia; Kotsonis, Paraskevas; Coghe, Ferdinando; Atzeni, Vinicio; Scartozzi, Mario; Antonio, Macciò
MLL riarrangement in acute myeloid leukemias
2007-01-01 Culurgioni, F; Loriga, R; Lilliu, S; Pala, G; Cardia, D; Soro, P; Murru, R; Romani, C; Ennas, MARIA GRAZIA; Angelucci, E.
Molecular analysis of HLA class II antigens in bone marrow transplanted thalassemic patients
1991-01-01 Andreani, M; Carcassi, Carlo; Nesci, S; Manna, M; Centis, F; LA NASA, Giorgio; Manca, Ml; Cornaglia Ferraris, P; Orru, Sandro; Lucarelli, G.
Myocardial iron overload assessment by T2*magnetic resonance imaging in adult transfusion dependent patients with acquired anemias
2008-01-01 Di Tucci, Aa; Matta, G; Deplano, S; Gabbas, A; Depau, C; Derudas, D; Caocci, Giovanni; Agus, A; Angelucci, E.
No evidence of cardiac iron in 20 never or minimally transfused patients with thalassemia intermedia
2008-01-01 Origa, Raffaella; Matta, G; Barella, S; Giagu, N; Argiolas, Gm; Agus, A; Bina, P; Galanello, R.
| Titolo | Data di pubblicazione | Autore(i) | Rivista | Editore |
|---|---|---|---|---|
| In vivo activation of the human δ-globin gene: the therapeutic potential in β- thalassemic mice | 1-gen-2014 | Manchinu M., F; Marongiu M., F; Poddie, D; Casu, C; Latini, Veronica; Simbula, M; Galanello, R; Moi, Paolo; Cao, A; Porcu, S; Ristaldi, M. S. | HAEMATOLOGICA | - |
| Incidence of non-Hodgkin's lymphoma and Hodgkin's disease in Sardinia, Italy: 1974-1993 | 1-gen-2001 | Broccia, G; Cocco, PIER LUIGI; Casula, P. | HAEMATOLOGICA | - |
| Incidenza del difetto della G-6-PD eritrocitaria, della ß e α-Talassemia nella Sardegna Meridionale: risultati di tre anni di screening | 1-gen-1985 | Frigerio, R; Cacace, Enrico; Sole, G; Olla, N; Lovicu, M; Passiu, G; Perpignano, G; Pitzus, F; Carcassi, U. | HAEMATOLOGICA | - |
| Interferon-alpha 2a therapy in CML: disappearance of BCR/ABL transcript in a case of long-lasting continuous cytogenetic conversion | 1-gen-1994 | Pardini, S; Addis, Maria; Dore, F; Bonfigli, S; Nieddu, Rm; Galanello, R; Longinotti, M; Pau, Mg | HAEMATOLOGICA | - |
| INTERIM RESULTS FROM A PHASE 2A, OPEN-LABEL, DOSE FINDING STUDY OF SOTATERCEPT (ACE-011) IN ADULT PATIENTS (PTS) WITH BETA-THALASSEMIA | 1-gen-2015 | Cappellini, Md; Porter, J; Origa, Raffaella; Forni, Gl; Voskaridou, E; Taher, At; Laadem, A; Galacteros, F; Miteva, D; Sung, V; Chopra, R; Arlet, Jb; Ribeil, Ja; Zou, J; Chen, N; Attie, Km; Garbowski, M; Graziadei, G; Balocco, M; Hermine, O. | HAEMATOLOGICA | - |
| INTERIM RESULTS FROM A PHASE 2A, OPEN-LABEL, DOSE-FINDING STUDY TO DETERMINE THE SAFETY, EFFICACY, AND TOLERABILITY OF SOTATERCEPT (ACE-011) IN ADULTS WITH BETA-THALASSEMIA | 1-gen-2014 | Porter, J; Cappellini, Md; Origa, Raffaella; Forni, Gl; Laadem, A; Galacteros, F; Voskaridou, E; Miteva, D; Sung, V; Chopra, R; Arlet, Jb; Ribeil, Ja; Klesczewski, K; Attie, K; Garbowski, M; Graziadei, G; Balocco, M; Hermine, O. | HAEMATOLOGICA | - |
| Internal tandem duplication, d835 mutation in acute myeloid and promielocitic leukemia | 1-gen-2005 | Culurgioni, F; Ennas, MARIA GRAZIA; Adamo, Mf; Pala, G; Tavera, Ml; Zucca, Mariagrazia; Lilliu, S; Angelucci, E. | HAEMATOLOGICA | - |
| INVESTIGATING PRETREATMENT QUALITY OF LIFE AND SYMPTOMATOLOGY IN NEWLY DIAGNOSED HIGH-RISK PATIENTS WITH MYELODYSPLASIA. GIMEMA AND EORTC QUALITY OF LIFE GROUP | 1-gen-2010 | Efficace, F; Angelucci, E; Sprangers, M; Gaidano, G; Caocci, Giovanni; Breccia, M; Voso, Mt; Staudere, R; Selleslag, D; Lubbert, M; Cascavilla, N; Rauzy, B; Chonghua, W; Specchia, G; Chie, W; Focan, C; Cottone, F; Vignetti, M; Mandelli, F. | HAEMATOLOGICA | - |
| Iron chelation therapy with deferasirox in transfusion dependent myelodysplastic syndrome patients. first report From the prospective MDS0306 gimema trial | 1-gen-2010 | Angelucci, E; Di Tucci, A; Santini, V; Poliani, E; Finelli, C; Della Casa, C; Cantore, N; Caocci, Giovanni; D’Arco, Am; Vallisa, D; Foà, R; Quarta, G; Morra, E; Annino, L; Saglio, G; Cascavilla, N; Levis, A; Porcedda, S; Picciocchi, A; Vignetti, M; Tura, S. | HAEMATOLOGICA | - |
| Iron chelation therapy with deferasirox in transfusion dependent myelodysplastic syndrome patients. Report from the prospective MDS0306 GIMEMA trial | 1-gen-2011 | Angelucci, E; Santini, V; Caocci, Giovanni; Rambaldia, A; Finelli, C; Pogliani, Em; Quarta, G; Di Tucci, A; Levis, A; Cantore, N; D'Arco, Am; Saglio, G; Cascavilla, N; Morra, E; Vallisa, D; Alimena, G; Voro, Mt; Annino, L; Pilo, F; Piciocchi, A; Vignetti, M; Tura, S. | HAEMATOLOGICA | - |
| Is the experience mutation of G-CSF truly a predictive indicator of trends in early myolodysplasia or leukemia? | 1-gen-2008 | Tucci, F; Giunti, L; Gambineri, Eleonora; Tondo, A; Giglio, SABRINA RITA; Sainati, L; Arico, M. | HAEMATOLOGICA | - |
| Kir haplotype aa is a possible predictive marker of complete molecular response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia | 1-gen-2013 | Caocci, Giovanni; LA NASA, Giorgio; Littera, R; Atzeni, S; Vacca, A; Mulas, O; Langiu, M; Greco, M; Orru, Sandro; Orrù, N; Usai, M; Floris, A; Carcassi, Carlo | HAEMATOLOGICA | - |
| La ferritina sierica nei Beta -talassemici dopo trapianto di midollo osseo: dati preliminari su due diversi tipi di comportamento | 1-gen-1987 | LA NASA, Giorgio; Arras, M; Vacca, A; Pizzati, A; Zuccarelli, A; Atzeni, S; Mela, Quirico; ZORCOLO G., P; Mulargia, M; Carcassi, Carlo; Lucarelli, G; Contu, L. | HAEMATOLOGICA | - |
| Livelli della HbA1c in soggetti G-6-PD carenti | 1-gen-1985 | Frigerio, R; Passiu, G; Sole, G; Olla, N; Lovicu, M; Mela, Quirico; Perpignano, G; Pitzus, F; Carcassi, U. | HAEMATOLOGICA | - |
| Liver iron concentrations and urinary hepcidin in beta-thalassemia | 1-gen-2007 | Origa, Raffaella; Galanello, R; Ganz, T; Giagu, N; Maccioni, L; Faa, Gavino; Nemeth, E. | HAEMATOLOGICA | - |
| Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: Key role of interleukin-6 | 1-gen-2018 | Madeddu, Clelia; Gramignano, Giulia; Kotsonis, Paraskevas; Coghe, Ferdinando; Atzeni, Vinicio; Scartozzi, Mario; Antonio, Macciò | HAEMATOLOGICA | - |
| MLL riarrangement in acute myeloid leukemias | 1-gen-2007 | Culurgioni, F; Loriga, R; Lilliu, S; Pala, G; Cardia, D; Soro, P; Murru, R; Romani, C; Ennas, MARIA GRAZIA; Angelucci, E. | HAEMATOLOGICA | - |
| Molecular analysis of HLA class II antigens in bone marrow transplanted thalassemic patients | 1-gen-1991 | Andreani, M; Carcassi, Carlo; Nesci, S; Manna, M; Centis, F; LA NASA, Giorgio; Manca, Ml; Cornaglia Ferraris, P; Orru, Sandro; Lucarelli, G. | HAEMATOLOGICA | - |
| Myocardial iron overload assessment by T2*magnetic resonance imaging in adult transfusion dependent patients with acquired anemias | 1-gen-2008 | Di Tucci, Aa; Matta, G; Deplano, S; Gabbas, A; Depau, C; Derudas, D; Caocci, Giovanni; Agus, A; Angelucci, E. | HAEMATOLOGICA | - |
| No evidence of cardiac iron in 20 never or minimally transfused patients with thalassemia intermedia | 1-gen-2008 | Origa, Raffaella; Matta, G; Barella, S; Giagu, N; Argiolas, Gm; Agus, A; Bina, P; Galanello, R. | HAEMATOLOGICA | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile